Here, we report methylation profiling data supporting a similar mechanism in central CS, where specific IDH mutations are correlated with increased levels of the 2-HG oncometabolite3 compared with wt tumours, and a widespread hypermethylation phenotype. Here, IDH2 is linked to neoplasm.